DR. WILLEMS MARJON
ActiveDR. WILLEMS MARJON has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €68k and a net result of €27k. Equity is growing by ~19.5% per year across the filed fiscal years. Its solvency ranks better than 16% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
72
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability79▲+6
Solvency47▲+3
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity tight (current ratio 1.33 against 1.14 in 2023; short-term debt: 6.9% and cash: 5.1% of total assets), and 78.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
21.8%
Return on assets
8.6%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 19908 sector peers (2024).
NBB · sector comparisonPosition among 19908 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
34 d early
2023
33 d early
2022
31 d early
2021
3 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€68k▲ 10.5%
2023 · €62k
2021: €38k
2022: €50k
2023: €62k
2021 → 2024
Total assets
€314k▼ 4.6%
2023 · €329k
2021: €52k
2022: €61k
2023: €329k
2021 → 2024
Net result
€27k▲ 127%
2023 · €12k
2021: €34k
2022: €12k
2023: €12k
2021 → 2024
Working capital
€7k▲ 54.2%
2023 · €5k
2021: €38k
2022: €47k
2023: €5k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€38k-€50k▲ 30.9%€62k▲ 23.8%€68k▲ 10.5%
Operating result€44k-€18k▼ 59.7%€23k▲ 31.4%€43k▲ 85.9%
Net result€34k-€12k▼ 65.5%€12k▲ 0.7%€27k▲ 127%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 86% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €314k
Fixed assets
€285k▼ 1.8%
Current assets
€29k▼ 25.5%
Equity and liabilities €314k
Equity
€68k▲ 10.5%
Debt
€246k▼ 8.1%
The debt ratio falls from 81.2% to 78.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€61k▼
2023 · €66k
Cash flow
€45k▼
2023 · €54k
Solvency
21.8%▲
2023 · 18.8%
Current ratio
1.33▲
2023 · 1.14
Quick ratio
1.33▲
2023 · 1.14
Debt / equity
3.59▼
2023 · 4.32
ROE
39.4%▲
2023 · 19.2%
ROA
8.6%▲
2023 · 3.6%
Interest coverage
6.88▼
2023 · 7.77
Debt
€246k▼
2023 · €267k
Debt ≤ 1 year
€22k▼
2023 · €34k
Debt > 1 year
€224k▼
2023 · €233k
Income taxes
€7k▲
2023 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€329k€314k▼
Fixed assets21/28€290k€285k▼
Tangible fixed assets22/27€290k€285k▼
Land and buildings22€240k€230k▼
Plant, machinery and equipment23€5k€3k▼
Furniture and vehicles24€1k€0▼
Other tangible fixed assets26€44k€52k▲
Financial fixed assets28€44€44=
Current assets29/58€39k€29k▼
Amounts receivable within one year40/41€8k€13k▲
Trade receivables40€4k€10k▲
Other amounts receivable41€3k€3k▼
Cash at bank and in hand54/58€31k€16k▼
Deferred charges and accrued income490/1€0-
Equity and liabilities
Total equity and liabilities10/49€329k€314k▼
Equity10/15€62k€68k▲
Contributions10/11€4k€4k=
Reserves13€58k€64k▲
Distributable reserves133€58k€64k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€267k€246k▼
Amounts payable after more than one year17€233k€224k▼
Financial debts170/4€233k€224k▼
Amounts payable within one year42/48€34k€22k▼
Current portion of amounts payable after more than one year42€9k€9k▲
Trade debts44€21k€8k▼
Suppliers440/4€21k€8k▼
Taxes, remuneration and social security45€4k€0▼
Taxes450/3€4k€0▼
Other amounts payable47/48-€5k
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€42k€18k▼
Other operating charges640/8€1k€2k▲
Gross operating margin9900€67k€63k▼
Operating profit (loss)9901€23k€43k▲
Financial income75/76B€2€0▼
Recurring financial income75€2€0▼
Financial charges65/66B€8k€9k▲
Recurring financial charges65€8k€9k▲
Profit (loss) for the period before taxes9903€15k€34k▲
Income taxes67/77€3k€7k▲
Profit (loss) for the period9904€12k€27k▲
Profit (loss) for the period to be appropriated9905€12k€27k▲
Appropriation of the result
Profit (loss) to be appropriated9906€12k€27k▲
Transfer from equity791/2-€20k
Transfer to equity691/2€12k€27k▲
To other reserves6921€12k€27k▲
Profit to be distributed694/7-€20k
Return on contributions (dividend)694-€20k
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
28-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet €12k ▼65.5%
Net result drops to €12k, the lowest in the series; recovery starts the following year.
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brasschaat · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Molenweg 362930 BrasschaatGround area
436 m²
Building footprint
133 m²
Volume, LiDAR
715 m³
Parcel 11323F0068/00Z011, Flanders · tallest building 9.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. WILLEMS MARJON
since 20212.313.847.403
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11323F0068/00Z011 | Flanders | 436 m² | 1 · 133 m² | 9.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
NOLET MEDCO
BE 1002.567.848
Watermaal-Bosvoorde · Eq €69k
Dr. Vandeputte-Dr. Verleure
BE 0713.962.164
Deerlijk · Eq €69k
"Docteur Amélie VANDEN EYNDE"
BE 0699.944.377
Gerpinnes · Eq €68k
DOCTEUR CHLOE CREUTZ
BE 1014.525.968
Liège · Eq €69k
VEMA - MEDIC
BE 0446.975.604
Braine-le-Comte · Eq €68k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 4,938 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-02-2021
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.